• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mA RNA修饰调控透明细胞肾细胞癌中的基因表达及癌症相关通路。

mA RNA modification modulates gene expression and cancer-related pathways in clear cell renal cell carcinoma.

作者信息

Chen Yimeng, Zhou Cuixing, Sun Yangyang, He Xiaozhou, Xue Dong

机构信息

Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu, China.

出版信息

Epigenomics. 2020 Jan;12(2):87-99. doi: 10.2217/epi-2019-0182. Epub 2019 Dec 20.

DOI:10.2217/epi-2019-0182
PMID:31856595
Abstract

To systematically profile the global mA modification pattern in clear cell renal cell carcinoma (ccRCC). mA modification patterns in ccRCC and normal tissues were described via mA sequencing and RNA sequencing, followed by bioinformatics analysis. mA-related RNAs were immunoprecipitated and validated by quantitative real-time PCR (qPCR). In total, 6919 new mA peaks appeared with the disappearance of 5020 peaks in ccRCC samples. The unique mA-related genes in ccRCC were associated with cancer-related pathways. We identified differentially expressed mRNA transcripts with hyper-methylated or hypo-methylated mA peaks in ccRCC. This study presented the first mA transcriptome-wide map of human ccRCC, which may shed lights on possible mechanisms of mA-mediated gene expression regulation.

摘要

为系统地描绘透明细胞肾细胞癌(ccRCC)中的全局mA修饰模式。通过mA测序和RNA测序描述ccRCC和正常组织中的mA修饰模式,随后进行生物信息学分析。对与mA相关的RNA进行免疫沉淀,并通过定量实时PCR(qPCR)进行验证。在ccRCC样本中,总共出现了6919个新的mA峰,同时有5020个峰消失。ccRCC中独特的与mA相关的基因与癌症相关通路有关。我们在ccRCC中鉴定出具有高甲基化或低甲基化mA峰的差异表达mRNA转录本。本研究展示了首张人类ccRCC的全转录组mA图谱,这可能为mA介导的基因表达调控的潜在机制提供线索。

相似文献

1
mA RNA modification modulates gene expression and cancer-related pathways in clear cell renal cell carcinoma.mA RNA修饰调控透明细胞肾细胞癌中的基因表达及癌症相关通路。
Epigenomics. 2020 Jan;12(2):87-99. doi: 10.2217/epi-2019-0182. Epub 2019 Dec 20.
2
Analysis and verification of -methyladenosine-modified genes as novel biomarkers for clear cell renal cell carcinoma.分析和验证 -甲基腺苷修饰基因作为透明细胞肾细胞癌的新型生物标志物。
Bioengineered. 2021 Dec;12(2):9473-9483. doi: 10.1080/21655979.2021.1995574.
3
Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.鉴定和验证肾透明细胞癌中 m6A 相关的铁死亡基因。
Cell Biol Int. 2024 Jun;48(6):777-794. doi: 10.1002/cbin.12146. Epub 2024 Mar 5.
4
IGF2BP2 inhibits invasion and migration of clear cell renal cell carcinoma via targeting Netrin-4 in an mA-dependent manner.IGF2BP2 通过靶向 Netrin-4 以 mA 依赖性方式抑制透明细胞肾细胞癌的侵袭和迁移。
Mol Carcinog. 2024 Aug;63(8):1572-1587. doi: 10.1002/mc.23746. Epub 2024 May 23.
5
The mA RNA Modification Modulates Gene Expression and Fibrosis-Related Pathways in Hypertrophic Scar.mA RNA修饰调节肥厚性瘢痕中的基因表达和纤维化相关通路。
Front Cell Dev Biol. 2021 Nov 15;9:748703. doi: 10.3389/fcell.2021.748703. eCollection 2021.
6
-Mediated Regulation of mA-Modified by mA Reader IGF2BP3 Drives ccRCC Progression.-mA 修饰物 IGF2BP3 通过 mA 阅读器介导的调控驱动 ccRCC 进展。
Cancer Res. 2021 Feb 15;81(4):923-934. doi: 10.1158/0008-5472.CAN-20-1619. Epub 2020 Dec 8.
7
N -Methyladenosine (m A) readers are dysregulated in renal cell carcinoma.N6 -甲基腺苷(m6A)读码器在肾细胞癌中失调。
Mol Carcinog. 2021 May;60(5):354-362. doi: 10.1002/mc.23297. Epub 2021 Mar 23.
8
Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N-Methyladenosine RNA Methylation Regulators.基于 N6-甲基腺苷 RNA 甲基化调控因子鉴定透明细胞肾细胞癌的新预后风险特征。
J Immunol Res. 2021 Feb 12;2021:6617841. doi: 10.1155/2021/6617841. eCollection 2021.
9
N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.N6-甲基腺苷修饰的 ALDH9A1 通过 NPM1/IQGAP2/AKT 信号通路调节透明细胞肾细胞癌中的脂质积累和肿瘤进展。
Cell Death Dis. 2024 Jul 22;15(7):520. doi: 10.1038/s41419-024-06896-z.
10
EGR2-mediated regulation of mA reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization.EGR2介导的mA阅读器IGF2BP蛋白调控通过增强S1PR3 mRNA稳定性驱动肾细胞癌的肿瘤发生和转移。
Cell Death Dis. 2021 Jul 29;12(8):750. doi: 10.1038/s41419-021-04038-3.

引用本文的文献

1
Targeting mA RNA Modification in Tumor Therapeutics.肿瘤治疗中针对 mA RNA 修饰
Curr Oncol. 2025 Mar 11;32(3):159. doi: 10.3390/curroncol32030159.
2
Investigating the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma based on methylation cross talk scoring.基于甲基化相互作用评分研究免疫检查点抑制剂在透明细胞肾细胞癌中的疗效。
Medicine (Baltimore). 2025 Mar 14;104(11):e41795. doi: 10.1097/MD.0000000000041795.
3
Understanding m6A changes in chromophobe renal cell carcinoma and predicting patient outcomes survival.
理解嗜色性肾细胞癌中 m6A 的变化并预测患者预后生存。
BMC Cancer. 2024 Sep 27;24(1):1187. doi: 10.1186/s12885-024-12956-6.
4
Pan-cancer Analysis Reveals m6A Variation and Cell-specific Regulatory Network in Different Cancer Types.泛癌症分析揭示了不同癌症类型中 m6A 变异和细胞特异性调控网络。
Genomics Proteomics Bioinformatics. 2024 Oct 15;22(4). doi: 10.1093/gpbjnl/qzae052.
5
The mA demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance.mA 去甲基化酶 FTO 靶向 POLQ 以促进 ccRCC 细胞增殖和基因组稳定性维持。
J Cancer Res Clin Oncol. 2024 Jan 25;150(2):30. doi: 10.1007/s00432-023-05541-0.
6
METTL3 facilitates renal cell carcinoma progression by PLOD2 mA-methylation under prolonged hypoxia.METTL3 通过在长期缺氧下 PLOD2 mA-甲基化促进肾细胞癌进展。
Cell Death Dis. 2024 Jan 17;15(1):62. doi: 10.1038/s41419-023-06411-w.
7
N6-methyladenosine methylation in kidney injury.肾脏损伤中的N6-甲基腺苷甲基化
Clin Epigenetics. 2023 Oct 21;15(1):170. doi: 10.1186/s13148-023-01586-7.
8
The role of N6-methyladenosine (mA) in kidney diseases.N6-甲基腺苷(m6A)在肾脏疾病中的作用。
Front Med (Lausanne). 2023 Sep 28;10:1247690. doi: 10.3389/fmed.2023.1247690. eCollection 2023.
9
The current landscape of m6A modification in urological cancers.尿路上皮癌中 m6A 修饰的现状。
PeerJ. 2023 Sep 7;11:e16023. doi: 10.7717/peerj.16023. eCollection 2023.
10
Development and verification of a deep learning-based mA modification model for clinical prognosis prediction of renal cell carcinoma.基于深度学习的肾细胞癌临床预后预测毫安修正模型的开发与验证
J Cancer Res Clin Oncol. 2023 Nov;149(15):14283-14296. doi: 10.1007/s00432-023-05169-0. Epub 2023 Aug 10.